Buy or sell Aetion stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Aetion Stock

Analytics solutions for life science companies

Founded

2013

Notable Investors

Amgen Ventures

Headquarters

New York NY, US

Total Funding

$74.6M

About Aetion Stock

Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.

Investors

Funding History

March 2017$11.2M
April 2018$36.4M
February 2019$27.0M

Management

Chief Executive Officer

Carolyn Magill

Co-Founder & Chief Science Officer

Jeremy Rassen

Chief Technology Officer

Selvam Velmurugan

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Aetion or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo